contract with H.I. Next or what other firms bid on the work. Catford commented only that "I feel honoured to work with (CAMH) and I feel like it has been done ethically." In interviews with the Toronto Star, Dev Chopra, executive vice-president of CAMH first said there was nothing inappropriate about Catford's role. "We got into it with our eyes open. There is no conflict." However, Chopra later said there were "some optics from a conflict perspective" noting the hospital might revisit the issue that day. Catford left his CAMH position two days later, but the Star reported that hospital officials said changes were being considered months before the Star published its story about the issue. Criticisms CAMH's administration has come under criticism including from staff who report safety problems and from donors who withdrew their funding citing accountability problems. David Healy Affair Soon after CAMH was founded, its administration was embroiled in a scandal involving Eli Lilly and Company, which donated $1.5 million to CAMH, and David Healy, a prominent critic of Prozac, the widely used antidepressant manufactured by Eli Lilly. CAMH hired Healy to be the head of its Mood and Anxiety Program, but withdrew the job offer after hearing about Healy's views. CAMH aggressively recruited Healy, and CAMH Physician-in-Chief, David Goldbloom, offered Healy a job as the head of the Mood and Anxiety Program. Healy accepted and soon after gave a lecture in which he reiterated his views about Prozac increasing risk of suicide. A few days later, Goldbloom withdrew the job offer, saying "Essentially, we believe that it is not a good fit between you and the role as leader of an academic program in mood and anxiety disorders at the centre and in relation to the university….We do not feel your approach is compatible with the goals for development of the academic and clinical resource that we have." The decision caused an "uproar" among Canadian academics, with the Canadian Association of University Teachers calling CAMH actions "an affront to academic freedom in Canada." Scientists from 13 countries, including Nobel laureates Julius Axelrod and Arvid Carlsson, protested CAMH's actions as did the Society for Academic Freedom and Scholarship (SAFS). Healy sued CAMH and the University of Toronto, alleging breach of contract, defamation, and denial of academic freedom. The lawsuit sought damages of $9.4 million, including $2.6 million from CAMH CEO Paul Garfinkel, and $1.4 million from